English | Español
Patient Daily | Feb 9, 2026

FDA faces major leadership turnover and regulatory shifts following Trump administration actions
Patient Daily | Feb 8, 2026

AstraZeneca acquires full rights to AbelZeta’s cancer therapy for $630 million
Patient Daily | Feb 8, 2026

GSK acquires RAPT Therapeutics for $2.2B under new CEO Luke Miels
Patient Daily | Feb 8, 2026

Biohaven outlines new strategy after setbacks and prepares muscle-sparing drug study
Patient Daily | Feb 8, 2026

CDMOs look to FDA's PreCheck program for support at new US production sites
Patient Daily | Feb 8, 2026

Penn Medicine earns national recognition for top clinical research achievements
Patient Daily | Feb 8, 2026

ACAAI offers guidance for an allergy-safe Valentine’s Day
Patient Daily | Feb 8, 2026

HonorHealth Research Institute administers new investigational stroke drug as part of national trial

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Alliance for Consumers releases update on trial law firm political donations
+ Pharmaceuticals
Patient Daily | Mar 27, 2026

Bayer asks Supreme Court to protect federal regulation from state tort litigation
+ Regulatory
A. D. Brady | Mar 30, 2026

Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’